Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
Abdul Muqtadir Abbasi, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
”How do hematologist know, which coagulation factor is the problem?
PT, aPTT and Fibrinogen: a practical clotting-factor algorithm
PT prolonged, aPTT normal
- Think FVII deficiency
- Check FVII assay
PT normal, aPTT prolonged
- Think VIII, IX, XI, XII
- Do a mixing study
Corrects means factor deficiency, followed by factor assays
Fails to correct means inhibitor/heparin, so investigate further
PT prolonged and aPTT prolonged
- Think common pathway (II, V, X, fibrinogen) or multiple-factor deficiency
- Check fibrinogen, D-dimer, platelets, LFTs and medication history
PT prolonged and aPTT prolonged and fibrinogen decreased
- Strongly consider DIC/consumption
Rule of thumb: Screen, followed by mixing study, followed by factor assay, followed by confirmation of the diagnosis
So what exactly is mixing studies?
Lets make it very simple.
We take patient plasma and add normal plasma with it.
If there is a deficiency of a certain factor, the addition of normal plasma with patient plasma will correct the deficiency and pt/ptt will become normal, which will prove deficiency, that can be confirmed by factor assay.
If addition if it doesnt correct pt/ptt, means there is actually an inhibitor of that particular factor that is also not allowing combining the normal plasma work.”
Other posts featuring Abdul Muqtadir Abbasi on Hemostasis Today.
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research